How Telehealth Weight Loss Works: A Step-by-Step Guide

The telehealth weight loss journey begins with a comprehensive health assessment. At Weight Method, this is a guided online questionnaire that takes approximately 5-10 minutes to complete. You answer questions about your physical characteristics (height, weight, age), medical history, current medications, allergies, family health history, and weight management goals.

The assessment is designed to collect the same clinical information a doctor would gather during an in-person visit. Every question serves a specific medical purpose. Height and weight determine your BMI, which is the primary eligibility criterion. Medical history questions screen for conditions that affect medication selection — type 2 diabetes, for example, may favor tirzepatide. Medication questions identify potential drug interactions. Family history questions screen for specific contraindications like medullary thyroid carcinoma.

You can complete the assessment at any time, on any device. There is no appointment to schedule and no waiting room. The information you provide is transmitted securely and becomes part of your medical record. Accuracy matters — your provider relies on this information to make safe prescribing decisions, so it is important to be thorough and honest in your responses.

Once you submit your assessment, a licensed healthcare provider reviews your information. At Weight Method, this is a physician or nurse practitioner licensed in your state who specializes in weight management and GLP-1 prescribing. The review typically happens within 24 hours of submission.

During the review, your provider evaluates several clinical factors. They calculate your BMI and confirm it meets the threshold for treatment (30+ or 27+ with comorbidities). They review your medical history for contraindications — conditions like medullary thyroid carcinoma, MEN 2, active pancreatitis, or pregnancy that would make GLP-1 treatment unsafe. They check your current medications for potential interactions, particularly with insulin or sulfonylureas. And they assess your overall health profile to determine which medication and dose are most appropriate.

The provider then makes one of three decisions: approve treatment with a specific medication and dose plan, request additional information before making a determination, or determine that GLP-1 treatment is not appropriate for your situation. If approved, you receive notification of your treatment plan. If additional information is needed, your provider contacts you with specific questions. If you do not qualify, you are informed of the reason and not charged for medication.

After your provider approves treatment, your prescription is sent to a licensed pharmacy partner for preparation. The pharmacy compounds your medication — semaglutide or tirzepatide — according to the dose specified by your provider. Quality controls including potency verification and sterility testing are performed before the medication is cleared for shipping.

Your medication is shipped directly to your home in temperature-controlled packaging. GLP-1 medications are proteins that must be kept within a specific temperature range to maintain their effectiveness. The packaging includes insulated containers and cold packs to ensure the medication arrives in optimal condition. Shipping typically takes 3-5 business days from the date of approval.

Your shipment includes the medication itself, injection supplies (syringes or prefilled pens), alcohol prep pads, and detailed administration instructions. The instructions cover injection technique, site selection (abdomen, thigh, or upper arm), site rotation, storage requirements (refrigerate at 36-46 degrees Fahrenheit), and what to do if you miss a dose. At Weight Method, your care team is also available to answer any questions about administration before your first injection.

Your first injection marks the beginning of a carefully managed dose escalation process. For semaglutide, treatment starts at 0.25 mg per week — a sub-therapeutic dose designed to let your gastrointestinal system adapt to the medication. For tirzepatide, the starting dose is 2.5 mg per week. These low starting doses minimize the nausea, constipation, and other GI side effects that are common when the body first encounters GLP-1 receptor activation.

The injection itself is simple. You clean the injection site with an alcohol prep pad, insert the fine-gauge needle at a 45-90 degree angle, inject the medication, and withdraw the needle. The entire process takes under a minute. Most patients report minimal discomfort — the needles used for GLP-1 injections are very fine, similar to those used for insulin. Choose the same day each week for your injection to maintain consistent medication levels.

Dose escalation follows a predetermined schedule managed by your provider. For semaglutide, the dose increases approximately every four weeks: 0.25 mg, then 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg. For tirzepatide: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg. Your provider confirms that you are tolerating each dose before approving the next increase. The full escalation takes 16-20 weeks for semaglutide and potentially longer for tirzepatide.

Telehealth weight loss is not a one-time transaction — it is an ongoing medical relationship. After starting treatment, your care team monitors your progress, manages side effects, and adjusts your treatment plan as needed. At Weight Method, this ongoing care is included in your monthly subscription with no additional fees.

During the dose escalation phase (the first 4-5 months), your provider checks in before each dose increase. They assess how you are tolerating the current dose, whether appetite suppression is occurring as expected, and whether any new symptoms have developed. If you experience significant side effects at a particular dose, the escalation can be paused — there is no pressure to increase on a rigid schedule. The goal is the lowest effective dose that produces consistent weight loss with manageable side effects.

Once you reach your maintenance dose, the cadence shifts to periodic check-ins and as-needed communication. Your medication continues to ship monthly. Your provider remains available for questions, concerns, or treatment adjustments. Over the long term, your care team helps you navigate the sustained phase of treatment — maintaining your weight loss, potentially adjusting doses, and making evidence-based decisions about treatment duration. At Weight Method, semaglutide is $297 per month and tirzepatide is $349 per month for as long as you continue treatment.